← Eichor
Condition: Kaposiform Hemangioendothelioma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Kaposiform Hemangioendothelioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP
Phase 2/Phase 3 · 1 location(s) · Yi Ji · NCT07656909Identification of Biomarkers for Patients with Vascular Anomalies
Phase N/A · 2 location(s) · Children's Hospital Medical Center, Cincinnati · NCT03001180Lymphatic Anomalies Registry for the Assessment of Outcome Data
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT02399527The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT05351216
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.